ADIA Nutrition Hires Marketing Company to Boost Social Media Presence and Expand Advertising Efforts for Supplement Division

Winter Park, Florida–(Newsfile Corp. – August 15, 2024) – Adia Nutrition Inc. (OTC Pink: ADIA), a growing health and wellness company, has announced a strategic partnership with Cornerstone Marketing Inc, a premier marketing and advertising firm, to enhance the brand’s social media presence and expand its advertising efforts across its entire product line, including the popular “Biolete Coffee,” now available on Amazon (Amazon.com: The Mushroom Coffee with 10 Grams of Protein by Biolete Premium Coffee Extract with Collagen, Chaga, Lions Mane & L-Theanine 20 Servings: Grocery & Gourmet Food). Additionally, Adia Nutrition aims to leverage Cornerstone Marketing Inc’s expertise to increase views and customers for “Cement Factory,” a supplement company in which Adia Nutrition holds a stake.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/219898_pouringaservingofbiolete_cafelatte-cropped.jpg

As part of the collaboration, Cornerstone Marketing Inc will take charge of managing and executing Adia Nutrition’s social media strategies, aiming to increase brand awareness, engagement, and customer reach across various platforms including Amazon. Cornerstone will also be responsible for assisting ADIA Nutrition with developing and implementing innovative advertising campaigns to promote the unique benefits and features of Adia Nutrition’s products, with a particular focus on “Biolete Coffee” and “Cement Factory.” Cornerstone Marketing Inc will focus on increasing visibility and driving customer engagement through targeted social media and influencer marketing campaigns.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/219898_cornerstone_marketing.jpg

In addition to traditional marketing methods, Cornerstone Marketing Inc will be leveraging the power of influencers to further amplify Adia Nutrition’s message and engage with a broader audience. By collaborating with influencers, Cornerstone will help create authentic connections and foster a community of loyal customers around the Adia Nutrition brand.

“We are excited to partner with Cornerstone Marketing Inc to elevate our social media presence and expand our advertising efforts for Adia Nutrition as a whole,” said Larry Powalisz. “Their expertise in the industry, combined with their innovative approach to marketing, will be instrumental in helping us reach our target audience and drive growth for our product line, including ‘Biolete Coffee’ and ‘Cement Factory.'”

The collaboration between Adia Nutrition and Cornerstone Marketing Inc is set to begin immediately, with the first phase of the campaign expected to launch in the coming days.

For media inquiries or further information, please contact Larry Powalisz at ceo@adiamed.com or 321-788-0850.

About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division specializing in Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments for Multiple Sclerosis (MS). Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.

Website: www.adianutrition.com

Website: www.adia-med.com

Website: www.biolete.com

Website: www.cementfactory.com

Twitter (X): @ADIA_Nutrition

Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company’s current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company’s business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/219898

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

7 minutes ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

8 minutes ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

11 minutes ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

11 minutes ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

11 minutes ago

Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson’s Disease

MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…

11 minutes ago